Evidence map›Paper›PMID 40256306›Full record

ArticleCurrent urology2024

COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers in Italy.

Giorgio Mazzon, Stefania Ferretti, Emanuele Serafin, Francesco Claps, Pietro Acquati, Davide Brusa, Federico Germinale, Giuseppe Celentano, Andrea Pescuma, Andrea Vismara Fugini and 18 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Giorgio MazzonDepartment of Urology, AULSS7 Pedemontana, San Bassiano Hospital, Bassano del Grappa, Italy.
Stefania FerrettiDepartment of Urology, University Hospital of Pama, Parma, Italy.
Emanuele SerafinDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Francesco ClapsUrological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Pietro AcquatiDepartment of Urology, IRCCS Policlinico San Donato, Milan, Italy.
Davide BrusaDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Federico GerminaleDepartment of Urology, Humanitas Gradenigo Hospital, Turin, Italy.
Giuseppe CelentanoDepartment of Neurosciences, Reproductive and Oral Sciences, University of Naples Federico II, Naples, Italy.
Andrea PescumaUrology Department, University of Modena & Reggio Emilia, Modena, Italy.
Andrea Vismara FuginiDepartment of Urology, Poliambulanza Foundation Hospital, Brescia, Italy.
Davide CampobassoDepartment of Urology, University Hospital of Pama, Parma, Italy.
Umberto MaestroniDepartment of Urology, University Hospital of Pama, Parma, Italy.
Giovanni CostaDepartment of Urology, AULSS7 Pedemontana, San Bassiano Hospital, Bassano del Grappa, Italy.
Tonino MorenaDepartment of Urology, Poliambulanza Foundation Hospital, Brescia, Italy.
Flavia Di MarcoUrological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Andrea BaudoDepartment of Urology, IRCCS Policlinico San Donato, Milan, Italy.
Massimiliano CretaDepartment of Neurosciences, Reproductive and Oral Sciences, University of Naples Federico II, Naples, Italy.
Nicola PavanUrology Section, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
Marco TiconoscoUrology Department, University of Modena & Reggio Emilia, Modena, Italy.
Angelo PeroniDepartment of Urology, Poliambulanza Foundation Hospital, Brescia, Italy.
Devis ColluraDepartment of Urology, Humanitas Gradenigo Hospital, Turin, Italy.
Maria Angela CerrutoDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Alessandro AntonelliDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
Luca CarmignaniDepartment of Urology, IRCCS Policlinico San Donato, Milan, Italy.
Salvatore MicaliUrology Department, University of Modena & Reggio Emilia, Modena, Italy.
Carlo TrombettaUrological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Giovanni MutoDepartment of Urology, Humanitas Gradenigo Hospital, Turin, Italy.
Antonio CeliaDepartment of Urology, AULSS7 Pedemontana, San Bassiano Hospital, Bassano del Grappa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coronavirus disease (COVID-19) pandemic has posed challenges to the global health care community, affecting the management of upper urinary tract stones. Materials and methods: This retrospective study involved 9 Italian centers. We compared the 12-month period prior to COVID-19 (March 1, 2019, to February 28, 2020; Period A) with the COVID-19 period (March 1, 2020, to February 28, 2021, Period B). This study aimed to compare outcomes during Periods A and B, specifically focusing on the overall number of treatments, rate of urgent/elective cases, and operational complexity. Results: A total of 4018 procedures were collected, comprising 2176 procedures during Period A and 1842 during Period B, indicating a loss of 15.35% ( Conclusions: Our study demonstrates that COVID-19 significantly disrupted endourological services across the country. Our data underline how patients received treatment over a prolonged period, potentially increasing the risk of stone-related complications and patient discomfort.

Indexed as

COVID-19Extracorporeal shock wave lithotripsyPercutaneous nephrolithotomyRetrograde intrarenal surgeryUrolithiasis

Identifiers

PMID40256306
PMCPMC12004962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.